175 related articles for article (PubMed ID: 17629366)
1. Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery.
Soler E; Parez N; Passet B; Dubuquoy C; Riffault S; Pillot M; Houdebine LM; Schwartz-Cornil I
Vaccine; 2007 Aug; 25(34):6373-80. PubMed ID: 17629366
[TBL] [Abstract][Full Text] [Related]
2. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
3. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
4. Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice.
McNeal MM; Basu M; Bean JA; Clements JD; Choi AH; Ward RL
Virology; 2007 Jul; 363(2):410-8. PubMed ID: 17337285
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.
Dennehy M; Bourn W; Steele D; Williamson AL
Vaccine; 2007 May; 25(18):3646-57. PubMed ID: 17339069
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
[TBL] [Abstract][Full Text] [Related]
7. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
Shuttleworth G; Eckery DC; Awram P
Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236
[TBL] [Abstract][Full Text] [Related]
8. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
9. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants.
Yang Y; Li X; Yang H; Qian Y; Zhang Y; Fang R; Chen X
Sci China Life Sci; 2011 Jan; 54(1):82-9. PubMed ID: 21104033
[TBL] [Abstract][Full Text] [Related]
11. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.
Agnello D; Hervé CA; Lavaux A; Darniot M; Guillon P; Charpilienne A; Pothier P
J Virol; 2006 Apr; 80(8):3823-32. PubMed ID: 16571799
[TBL] [Abstract][Full Text] [Related]
12. Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system.
Bellido D; Craig PO; Mozgovoj MV; Gonzalez DD; Wigdorovitz A; Goldbaum FA; Dus Santos MJ
Vaccine; 2009 Jan; 27(1):136-45. PubMed ID: 18973781
[TBL] [Abstract][Full Text] [Related]
13. VP6: A candidate rotavirus vaccine.
Ward RL; McNeal MM
J Infect Dis; 2010 Sep; 202 Suppl():S101-7. PubMed ID: 20684688
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and immunogenicity evaluation of rotavirus structural proteins as candidate vaccine.
El-Senousy WM; Shahein YE; Barakat AB; Ghanem HE; El-Hakim AE; Ameen SM
Int J Biol Macromol; 2013 Aug; 59():67-71. PubMed ID: 23588003
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection.
Dong JL; Liang BG; Jin YS; Zhang WJ; Wang T
Virology; 2005 Sep; 339(2):153-63. PubMed ID: 15992851
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
Zhou B; Zhang Y; Wang X; Dong J; Wang B; Han C; Yu J; Li D
Vaccine; 2010 Aug; 28(37):6021-7. PubMed ID: 20637305
[TBL] [Abstract][Full Text] [Related]
17. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
18. Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine.
Lappalainen S; Pastor AR; Malm M; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Arch Virol; 2015 Aug; 160(8):2075-8. PubMed ID: 26016444
[TBL] [Abstract][Full Text] [Related]
19. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
[TBL] [Abstract][Full Text] [Related]
20. Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits.
Soler E; Le Saux A; Guinut F; Passet B; Cohen R; Merle C; Charpilienne A; Fourgeux C; Sorel V; Piriou A; Schwartz-Cornil I; Cohen J; Houdebine LM
Transgenic Res; 2005 Dec; 14(6):833-44. PubMed ID: 16315090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
